ISIN | CH1238288042 |
---|---|
Valor Number | 123828804 |
Bloomberg Global ID | |
Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity I |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
Peculiarities |
Current Price * | 99.83 CHF | 21.11.2024 |
---|---|---|
Previous Price * | 99.52 CHF | 20.11.2024 |
52 Week High * | 106.99 CHF | 30.08.2024 |
52 Week Low * | 96.32 CHF | 14.02.2024 |
NAV * | 99.83 CHF | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 195,276,661 | |
Unit/Share Assets *** | 94,420,542 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
1 month | -5.37% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -5.31% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -4.71% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +3.64% |
14.02.2024 - 21.11.2024
14.02.2024 21.11.2024 |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 12.34% | |
---|---|---|
Roche Holding AG | 10.28% | |
Novartis AG Registered Shares | 9.93% | |
ABB Ltd | 5.95% | |
UBS Group AG | 5.67% | |
Zurich Insurance Group AG | 4.45% | |
Sika AG | 4.11% | |
Lonza Group Ltd | 3.81% | |
Givaudan SA | 3.51% | |
Alcon Inc | 3.39% | |
Last data update | 31.07.2024 |
TER | 0.61% |
---|---|
TER date | 15.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |